OTCMKTS:OSIR

Osiris Therapeutics (OSIR) Stock Price, News & Analysis

Osiris Therapeutics logo
$18.99 0.00 (0.00%)
As of 04/17/2019

About Osiris Therapeutics Stock (OTCMKTS:OSIR)

Key Stats

Today's Range
$18.99
▼
$18.99
50-Day Range
$18.99
▼
$18.99
52-Week Range
$7.01
▼
$19.30
Volume
N/A
Average Volume
205,753 shs
Market Capitalization
$655.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Osiris Therapeutics was a regenerative medicine company focused on developing and commercializing biologic products for wound care and orthopedic applications. Its products used donated human tissue to support tissue repair and healing.

Its product portfolio included Grafix, a placental membrane product used in wound care, and Stravix, made from umbilical tissue. Osiris also developed orthopedic products including Cartiform, an osteochondral allograft, and BIO4, a cellular bone matrix.

Smith & Nephew acquired Osiris in 2019, bringing its regenerative medicine products into the larger medical technology company’s portfolio. Osiris had been headquartered in Columbia, Maryland.

AI Generated. May Contain Errors.

Receive OSIR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Osiris Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OSIR Stock News Headlines

Osiris Chairman responds to column
A little-known law has been quietly applied to your savings for years.
Fox News reported that under current law, legal title to most stocks and bonds sits with a central institution, Cede and Company, not the individual investor. If a brokerage collapses and customer securities were pledged as collateral, secured creditors can legally come before account holders. Physical gold held in a self-directed IRA is registered directly to you, with no clearinghouse or central institution holding its title.tc pixel
See More Headlines

OSIR Stock Analysis - Frequently Asked Questions

Osiris Therapeutics' stock was trading at $18.99 on January 1st, 2026. Since then, OSIR stock has increased by 0.0% and is now trading at $18.99.

Based on aggregate information from My MarketBeat watchlists, some other companies that Osiris Therapeutics investors own include MiMedx Group (MDXG), Novavax (NVAX), Shopify (SHOP), Clean Energy Fuels (CLNE), Neuralstem (CUR), Cytokinetics (CYTK) and Exact Sciences (EXAS).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:OSIR
Previous Symbol
NASDAQ:OSIR
CIK
1360886
Fax
N/A
Employees
342
Year Founded
1992

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
34,528,000
Free Float
N/A
Market Cap
$655.69 million
Optionable
Not Optionable
Beta
N/A

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (OTCMKTS:OSIR) was last updated on 4/17/2019 by MarketBeat.com Staff.
From Our Partners